Results 41 to 50 of about 155,399 (295)

Age Related Macular Degeneration and Total Hip Replacement Due to Osteoarthritis or Fracture: Melbourne Collaborative Cohort Study. [PDF]

open access: yesPLoS ONE, 2015
Osteoarthritis is the leading cause of total hip replacement, accounting for more than 80% of all total hip replacements. Emerging evidence suggests that osteoarthritis has a chronic inflammatory component to its pathogenesis similar to age-related ...
Elaine W Chong   +8 more
doaj   +1 more source

Age-Related Macular Degeneration: Classification and Pathogenesis

open access: yesTürk Oftalmoloji Dergisi, 2014
Age-related macular degeneration (AMD) was first described in 1885 by Otto Haab as a disease in patients above 50 years of age with progressive retinal pigment epithelial and atrophic degenerations of the macula reducing the central visual acuity.
İmren Akkoyun
doaj   +1 more source

Primary prevention of age related macular degeneration. [PDF]

open access: yes, 2007
Current evidence does not support a protective role for dietary antioxidant ...
Evans, Jennifer
core   +2 more sources

Intravitreal aflibercept in neovascular age-related macular degeneration previously treated with ranibizumab

open access: yesInternational Journal of Ophthalmology, 2017
AIM: To report the change in visual acuity and central macular thickness (CMT) following treatment with intravitreal aflibercept injections in patients with neovascular age-related macular degeneration (nAMD) with suboptimum response to ranibizumab ...
Rachel Hui Fen Lim   +2 more
doaj   +1 more source

Plasma 25-Hydroxyvitamin-D (25-OHD) levels and late-stage age-related macular degeneration (AMD): Assessing the correlation

open access: yesJKKI (Jurnal Kedokteran dan Kesehatan Indonesia), 2022
Background: Age-related Macular Degeneration (AMD) is a degenerative disease caused by multiple factors, including inflammation. This condition may lead to irreversible macular damage.
Supanji Supanji   +11 more
doaj   +1 more source

Pachychoroid neovasculopathy and age-related macular degeneration. [PDF]

open access: yes, 2015
Pachychoroid neovasculopathy is a recently proposed clinical entity of choroidal neovascularization (CNV). As it often masquerades as neovascular age-related macular degeneration (AMD), it is currently controversial whether pachychoroid neovasculopathy ...
Akagi-Kurashige, Yumiko   +11 more
core   +1 more source

Beyond the Complement Cascade: Insights into Systemic Immunosenescence and Inflammaging in Age-Related Macular Degeneration and Current Barriers to Treatment

open access: yesCells, 2023
Landmark genetic studies have revealed the effect of complement biology and its regulation on the pathogenesis of age-related macular degeneration (AMD).
Adnan H. Khan   +2 more
doaj   +1 more source

Age-related macular degeneration [PDF]

open access: yesPostgraduate Medical Journal, 1998
Summary Macular degeneration is now responsible for approximately 95% of blindness and partial sighted registrations in the UK. This review has been written specifically to make the general medical community of the UK aware of the prevalence and clinical manifestations of aged-related macular degeneration. The review encompasses the risk
openaire   +2 more sources

The role of oxidative stress and antioxidants in the pathogenesis of age-related macular degeneration

open access: yesClinics, 2011
OBJECTIVE: To investigate the role of oxidant/antioxidant status and protein oxidation in the development of age-related macular degeneration. METHOD: The activities of serum superoxide dismutase and glutathione peroxidase and the levels of serum ...
Zuhal Yildirim   +2 more
doaj   +1 more source

Age-related macular degeneration: therapeutic modalities [PDF]

open access: yes, 2001
To describe the clinical and surgical therapeutic modalities in age-related macular degeneration (ARMD).Descrever as modalidades de tratamento clínico e cirúrgico das complicações da degeneração macular relacionada à idade (DMRI).Universidade Federal de ...
Costa, Rogerio Alves   +3 more
core   +2 more sources

Home - About - Disclaimer - Privacy